Follow The Filings

CRH CRH public Limited Company

Materials, filed as CRH PLC (ORD), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Bought by 6 managers in 2026 Q2, sold by 1

  • 2 Owners
  • #133
  • Max 3.1%
  • Master 0.06%
  • $302M
  • 1 reduce

In 2026 Q3 John Armitage trimmed CRH public.

Who owns this now

Largest portfolio weights among holders, up to 3.1% (John Armitage, Egerton Capital (UK)). Not free-float ownership.

  1. John Armitage Reduce 3.1%
  2. Greenhaven Associates 0.02%

Who owns CRH

Sorted by value, long equity only, as of 2026 Q3.

History
John Armitage, Egerton Capital (UK) 3.1%, was 4.5% Reduce −17.2% 3,631,232 $301M History
Greenhaven Associates 0.02% Hold 17,500 $1.4M History

2 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by CRH's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CRH insider trades
  • $601K bought by 2 insiders
  • $156K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Padraig ORiordain See Remarks
    Sale
    $156K 1,492 shares at $104.45 55% of stake
    Traded May 15 Filed May 18
    ↗
  2. Richard H Fearon Director
    Buy
    $397K 3,800 shares at $104.49 +2.7% to stake
    Traded Mar 11 Filed Mar 13
    ↗
  3. Siobhan Talbot Director
    Buy
    $204K 2,000 shares at $102.11 +36% to stake
    Traded Mar 12 Filed Mar 13
    ↗

Also filed in the last 12 months, not counted as buying or selling: 27 share withholdings for taxes, 24 option exercises, and 6 stock grants.

Congress

1 member of Congress traded CRH in the last three years: 0 buys and 1 sale. 1 member listed it in 2025 annual reports.

All Congress trades
  1. Val T. Hoyle D-OR-4Spouse Sell $1K–$15K Sep 23, 2025 filed Oct 10, 2025

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 8.01 Filing Doc
8-K 1.01,7.01,8.01,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 1.04 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 1 day ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $34.95B $35.57B $37.45B
Gross profit $11.96B $12.7B $13.53B
Gross margin * 34.2% 35.7% 36.1%
Net income $3.18B $3.49B $3.75B
Net margin * 9.1% 9.8% 10.0%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $16.88B $14.08B $15.25B
Total non-current assets * $30.58B $36.53B $43.08B
Total assets $47.47B $50.61B $58.33B
Total current liabilities $10.01B $10.3B $8.75B
Total non-current liabilities * $15.84B $17.47B $24.1B
Total equity $20.85B $21.61B $24B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $5.02B $4.99B $5.62B
Cash from investing -$2.39B -$6.29B -$6.04B
Cash from financing -$2.38B -$1.19B $0.596B
Net change in cash $0.454B -$2.63B $0.388B

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.